Test for amino acids in plasma and urine

The HUS Group requests tenders to procure test kit(s) for plasma and urine amino acids by liquid chromatography tandem mass spectrometry (LC-MS/MS) based technology. The test kit(s) should contain all needed assay dependent products like reagents, calibrators, the manufacturer’s control samples, the method parameters for the LC-MS/MS instrumentation, product support …

CPV: 33000000 Medical equipments, pharmaceuticals and personal care products
Deadline:
Aug. 31, 2026, 9 a.m.
Deadline type:
Submitting a bid
Place of execution:
Test for amino acids in plasma and urine
Awarding body:
HUS Group
Award number:
HUS 641-2024

1. Buyer

1.1 Buyer

Official name : HUS Group
Legal type of the buyer : Regional authority
Activity of the contracting authority : Health

2. Procedure

2.1 Procedure

Title : Test for amino acids in plasma and urine
Description : The HUS Group requests tenders to procure test kit(s) for plasma and urine amino acids by liquid chromatography tandem mass spectrometry (LC-MS/MS) based technology. The test kit(s) should contain all needed assay dependent products like reagents, calibrators, the manufacturer’s control samples, the method parameters for the LC-MS/MS instrumentation, product support and all other products needed for the assay except ordinary laboratory necessity, e.g. laboratory water, pipettes or glassware. The products are described in more detail in below in the invitation to tender. This is a total procurement, i.e. the procurement is not divided into lots. The offered solution must cover both plasma and urine testing. At present, the instrumentation available at HUS comprises LC from Shimadzu (Nexera 30 or 40) and MS/MS instruments from AB Sciex (5500+ Triple Quadrupole or Citrine) with Analyst MD 1.6.3. Hotfix 4 or SCIEX OS software versions. In addition, basic laboratory instrumentation like mixers, incubators, pipetting robots and centrifuges are available. The kits are intended for the detection and quantitative analysis of amino acids in plasma and urine. The amino acid profile allows diagnosis and monitoring of inborn errors of metabolism. At present, HUS runs approximately 1000 plasma and 200 urine patient sample tests yearly. The runs are performed in approximately 2-3 batches a week and about 5-10 samples in one batch. Samples should be able to prepare in vials. The contract period is 48 months. ESTIMATED VALUE At present, HUS runs approximately 1000 plasma and 200 urine patient sample tests yearly. This is an estimate and the contracting entity does not commit to the stated consumption figures indicated in the invitation to tender. The final order quantities may be higher or lower than stated. The subject matter and requirements of the procurement are described in detail in the invitation to tender and its annexes.
Procedure identifier : 51845076-1adc-462a-81bc-17fc2247b8c9
Internal identifier : HUS 641-2024
Type of procedure : Open
The procedure is accelerated : no
Main features of the procedure : The procurement shall comply with the Act on Public Procurement and Concession Contracts (1397/2016, referred to as the Public Procurement Act). The procurement value exceeds the EU threshold value. The procedure shall be an open procedure as defined in section 32 of the Public Procurement Act. PROCESSING OF TENDERS The procedure shall include the following phases: Contracting entity 1. Opens the tenders 2. Verifies the suitability of the tenderer 3. Checks that the tenders conform to the invitation to tender 4. Compares the tenders 5. Requests and checks certificates and reports on the suitability of the winning tenderer(s) 6. Makes a procurement decision and communicates it to all the tenderers 7. Concludes an agreement with the selected tenderer(s) LANGUAGE OF THE COMPETITIVE TENDERING PROCEDURE The procurement documents are available in English. If a tenderer needs the documents in another language, the tenderer shall be responsible for translation and liable for the associated costs. Tenders must be prepared in English. PARTIAL TENDERS Partial tenders will not be accepted. PARALLEL TENDERS Parallel tenders are not permitted.

2.1.1 Purpose

Main nature of the contract : Supplies
Main classification ( cpv ): 33000000 Medical equipments, pharmaceuticals and personal care products

2.1.2 Place of performance

Country : Finland
Anywhere in the given country

2.1.4 General information

Legal basis :
Directive 2014/24/EU

2.1.6 Grounds for exclusion

Sources of grounds for exclusion : European Single Procurement Document (ESPD)

5. Lot

5.1 Lot : LOT-0000

Title : Test for amino acids in plasma and urine
Description : The HUS Group requests tenders to procure test kit(s) for plasma and urine amino acids by liquid chromatography tandem mass spectrometry (LC-MS/MS) based technology. The test kit(s) should contain all needed assay dependent products like reagents, calibrators, the manufacturer’s control samples, the method parameters for the LC-MS/MS instrumentation, product support and all other products needed for the assay except ordinary laboratory necessity, e.g. laboratory water, pipettes or glassware. The products are described in more detail in below in the invitation to tender. This is a total procurement, i.e. the procurement is not divided into lots. The offered solution must cover both plasma and urine testing. At present, the instrumentation available at HUS comprises LC from Shimadzu (Nexera 30 or 40) and MS/MS instruments from AB Sciex (5500+ Triple Quadrupole or Citrine) with Analyst MD 1.6.3. Hotfix 4 or SCIEX OS software versions. In addition, basic laboratory instrumentation like mixers, incubators, pipetting robots and centrifuges are available. The kits are intended for the detection and quantitative analysis of amino acids in plasma and urine. The amino acid profile allows diagnosis and monitoring of inborn errors of metabolism. At present, HUS runs approximately 1000 plasma and 200 urine patient sample tests yearly. The runs are performed in approximately 2-3 batches a week and about 5-10 samples in one batch. Samples should be able to prepare in vials. The contract period is 48 months. ESTIMATED VALUE At present, HUS runs approximately 1000 plasma and 200 urine patient sample tests yearly. This is an estimate and the contracting entity does not commit to the stated consumption figures indicated in the invitation to tender. The final order quantities may be higher or lower than stated. The subject matter and requirements of the procurement are described in detail in the invitation to tender and its annexes.
Internal identifier : HUS 641-2024

5.1.1 Purpose

Main nature of the contract : Supplies
Main classification ( cpv ): 33000000 Medical equipments, pharmaceuticals and personal care products

5.1.2 Place of performance

Country : Finland
Anywhere in the given country
Additional information :

5.1.3 Estimated duration

Duration : 48 Month

5.1.6 General information

Reserved participation : Participation is not reserved.
Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA) : yes
This procurement is also suitable for small and medium-sized enterprises (SMEs) : yes

5.1.9 Selection criteria

Sources of selection criteria : European Single Procurement Document (ESPD)

5.1.10 Award criteria

Criterion :
Type : Price
Name : Kokonaishinta
Description : Hinta
Category of award weight criterion : Weight (points, exact)
Award criterion number : 1

5.1.11 Procurement documents

Deadline for requesting additional information : 19/08/2026 09:00 +00:00

5.1.12 Terms of procurement

Terms of submission :
Electronic submission : Required
Languages in which tenders or requests to participate may be submitted : English
Electronic catalogue : Not allowed
Tenderers may submit more than one tender : Not allowed
Deadline for receipt of tenders : 31/08/2026 09:00 +00:00
Duration during which the tender must remain valid : 9 Month
Information about public opening :
Opening date : 31/08/2026 09:15 +00:00
Terms of contract :
The execution of the contract must be performed within the framework of sheltered employment programmes : No
A non-disclosure agreement is required : no
Electronic invoicing : Required
Electronic ordering will be used : yes
Electronic payment will be used : yes

5.1.15 Techniques

Framework agreement :
No framework agreement
Information about the dynamic purchasing system :
No dynamic purchase system

5.1.16 Further information, mediation and review

Review organisation : Markkinaoikeus
Information about review deadlines : Precise information about the deadlines for the appeal procedure will be provided in the procurement decision.
Organisation providing more information on the review procedures : HUS Group

8. Organisations

8.1 ORG-0001

Official name : Markkinaoikeus
Registration number : 3006157-6
Postal address : Radanrakentajantie 5
Town : Helsinki
Postcode : 00520
Country subdivision (NUTS) : Helsinki-Uusimaa ( FI1B1 )
Country : Finland
Telephone : +358 295643300
Roles of this organisation :
Review organisation

8.1 ORG-0002

Official name : HUS Group
Registration number : 1567535-0
Postal address : Uutistie 5 (PO Box 441, 00029 HUS)
Town : Vantaa
Postcode : 01770
Country subdivision (NUTS) : Helsinki-Uusimaa ( FI1B1 )
Country : Finland
Contact point : Investments and diagnostics category
Telephone : +358 94711
Internet address : http://www.hus.fi
Roles of this organisation :
Buyer
Organisation providing more information on the review procedures

8.1 ORG-0003

Official name : Hansel Oy (Hilma)
Registration number : FI09880841
Postal address : Mannerheiminaukio 1a
Town : Helsinki
Postcode : 00100
Country subdivision (NUTS) : Helsinki-Uusimaa ( FI1B1 )
Country : Finland
Contact point : eSender
Telephone : 029 55 636 30
Roles of this organisation :
TED eSender

Notice information

Notice identifier/version : b3ad80ea-542b-4493-96ba-12c17e306869 - 01
Form type : Competition
Notice type : Contract or concession notice – standard regime
Notice dispatch date : 30/07/2026 06:28 +00:00
Notice dispatch date (eSender) : 30/07/2026 06:28 +00:00
Languages in which this notice is officially available : English
Notice publication number : 00532139-2026
OJ S issue number : 146/2026
Publication date : 31/07/2026